Active Ingredient Ipilimumab

Active Ingredient Details

What is Ipilimumab?

An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.

How many products in the NDC database contain Ipilimumab?

The NDC database has 7 products with the active ingredient Ipilimumab. The following table lists all the products that have this active ingredient.

NDC Products with Ipilimumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0003-2327Proprietary Name: Yervoy IpilimumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-2328Proprietary Name: Yervoy IpilimumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
71124-0001Proprietary Name: IpilimumabLiquidSamsung Biologics Co., Ltd.ACTIVE
71124-0020Proprietary Name: IpilimumabSolutionSamsung Biologics Co. LtdACTIVE
71124-0021Proprietary Name: IpilimumabSolutionSamsung Biologics Co. LtdACTIVE
71124-0022Proprietary Name: IpilimumabSolutionSamsung Biologics Co., Ltd.ACTIVE
83157-2327Proprietary Name: IpilimumabInjectionLotte Biologics Usa, LlcACTIVE
<